EMvision Medical Devices Ltd
ASX:EMV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.465
2.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
EMvision Medical Devices Ltd
EMvision Medical Devices Ltd
Accrued Liabilities
EMvision Medical Devices Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Accrued Liabilities
AU$371.1k
|
CAGR 3-Years
32%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
R
|
Respiri Ltd
ASX:RSH
|
Accrued Liabilities
AU$201.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Accrued Liabilities
AU$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cochlear Ltd
ASX:COH
|
Accrued Liabilities
AU$150.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
See Also
What is EMvision Medical Devices Ltd's Accrued Liabilities?
Accrued Liabilities
371.1k
AUD
Based on the financial report for Jun 30, 2024, EMvision Medical Devices Ltd's Accrued Liabilities amounts to 371.1k AUD.
What is EMvision Medical Devices Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
56%
Over the last year, the Accrued Liabilities growth was 19%. The average annual Accrued Liabilities growth rates for EMvision Medical Devices Ltd have been 32% over the past three years , 56% over the past five years .
You don't have any saved screeners yet
